Literature DB >> 20845057

Holmes-Adie syndrome associated with high altitude pulmonary edema and low chemo-responsiveness to hypoxia.

Jean-Paul Richalet1, Murielle Letournel, Jeffrey Salama.   

Abstract

A 63-year-old patient with Holmes-Adie syndrome presented an altered peripheral chemoreflex and suffered from high altitude pulmonary edema, suggesting an alteration of sensitive afferent fibers from the peripheral chemoreceptors. Chemo-responsiveness to hypoxia should be explored before any exposure to moderate altitude in Holmes-Adie patients.

Entities:  

Mesh:

Year:  2010        PMID: 20845057     DOI: 10.1007/s10286-010-0081-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  6 in total

1.  Holmes-Adie syndrome.

Authors:  P Martinelli
Journal:  Lancet       Date:  2000-11-18       Impact factor: 79.321

2.  Chronic cough and Holmes-Adie syndrome.

Authors:  Paul A Ford; Peter J Barnes; Omar S Usmani
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

3.  Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia.

Authors:  Luciano Bernardi; Max Hilz; Brigitte Stemper; Claudio Passino; Goetz Welsch; Felicia B Axelrod
Journal:  Am J Respir Crit Care Med       Date:  2002-10-24       Impact factor: 21.405

Review 4.  High altitude-induced pulmonary oedema.

Authors:  Marco Maggiorini
Journal:  Cardiovasc Res       Date:  2006-07-12       Impact factor: 10.787

5.  A role for succinate dehydrogenase genes in low chemoresponsiveness to hypoxia?

Authors:  Jean-Paul Richalet; Anne-Paule Gimenez-Roqueplo; Séverine Peyrard; Annabelle Vénisse; Laure Marelle; Nelly Burnichon; Anissa Bouzamondo; Xavier Jeunemaitre; Michel Azizi; Jean-Luc Elghozi
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

6.  Cardiovascular and sweating dysfunction in patients with Holmes-Adie syndrome.

Authors:  P J Bacon; S E Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.